CURE

FALL / 2007

Features

The HRT ConnectionAre breast cancer rates dropping because of the HRT decline, or are other factors at work?

BY ELIZABETH WHITTINGTON

The New Sarcoma StoryStrategies for diagnosing and treating sarcomas shift to a more patient-specific approach.

BY BEVERLY A. CALEY

Beneficial RiskQuestions about the safety of approved drugs has the FDA poised to reform.

BY JO CAVALLO AND JO CAVALLO

Contents

First Line

People, News & Events

EDITED BY STAFF

Diagnosis Cancer

Powers of PredictionPredictive markers help oncologists match patients with the most effective treatments. 

BY AMY K. ERICKSON

Finding Hope

Use As DirectedAs more cancer drugs become self-administered, why aren’t patients taking their medicine?  

BY LAURA BEIL

Moving On

All in the FamilyRegistries reveal links for cancer that runs in the family. 

BY CHARLOTTE HUFF

Caregivers' Corner

Grief Before DeathStruggling with the sorrow of anticipatory grief. 

BY MARC SILVER

In Every Issue

Editor's Page

Message from the EditorPopulation and personal impacts of hormone replacement therapy.

BY DEBU TRIPATHY, MD

Letters from Our Readers

Letters from Our Readers Readers respond to articles on never-smokers get lung cancer too, cancer & robots, and proton beam therapy, and finding Cure magazine.

Food for Thought

FDA Sets Rules for Dietary Supplements New regulations address what's in a supplement but not if it's safe or effective.

BY KATY HUMAN

Readers' Forum

The Good with the BadHow a paddle replaced anger with joy.

BY REGINA L. BUCHHOFER

Drugs in the News

Prostate Cancer & MDSSatraplatin's approval review deadline gets pushed back by the FDA and a large clinical trial shows Vidaza extends  survival in patients with MDS.

BY ELIZABETH WHITTINGTON

Speaking Out

Encouraging Innovations, Preserving SafetyMaintaining a balance between access to new drugs and protecting consumers.

BY ELLEN V. SIGAL, PHD

Web Exclusives

In Search of Quality MammographyHelpful tips for finding a certified mammography center near you.

BY LACEY MEYER

Progress in Treating Multiple MyelomaThe old and the new in myeloma therapy give patients more options.

BY PETER WEST